systemic lupus erythematosus

Drug Companies and NIH in $230 Million Joint Project for Alzheimer’s, Diabetes, Lupus and Arthritis

Drug Companies and NIH in $230 Million Joint Project for Alzheimer’s, Diabetes, Lupus and Arthritis

Along with funding from the United States government and ten large pharmaceutical companies, the National Institutes of Health (NIH), Bethesda, Maryland will split the cost of a new multimillion project targeting common chronic human diseases. The companies involved include Pfizer Inc., Eli Lilly & Co, AbbVie Inc., Biogen Idec Inc., Bristol-Myers Squibb Co., Glaxo Smith […]

Neuroendocrine Immunology of Rheumatic Diseases: A 10-Year Update

Neuroendocrine Immunology of Rheumatic Diseases: A 10-Year Update

In 2001, Drs. Rainer Straub and Maurizio Cutolo, established experts in the field of neuroendocrine immunology of autoimmune and rheumatic diseases, published a large overview on the role of diverse neural and hormonal factors in rheumatoid arthritis. In the last decade, Maurizio Cutolo, president of the European League against Rheumatism (EULAR) has also organized the […]

Leptin Induces Th17 Responses: Relevance to Systemic Lupus Erythematosus

Leptin Induces Th17 Responses: Relevance to Systemic Lupus Erythematosus

A new Cutting Edge article, in the April 2013 issue of the Journal of Immunology, identifies a link between leptin and T helper (Th)17 cells, based on the evidence that leptin was able to promote Th17 responses in human CD4+ T cells and in mice, both in vitro and in vivo, by inducing the transcription […]